{"id":305075,"date":"2025-11-21T11:53:09","date_gmt":"2025-11-21T11:53:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/305075\/"},"modified":"2025-11-21T11:53:09","modified_gmt":"2025-11-21T11:53:09","slug":"fda-calendar-these-are-the-upcoming-fda-drug-approvals","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/305075\/","title":{"rendered":"FDA Calendar: These Are the Upcoming FDA Drug Approvals\u00a0"},"content":{"rendered":"

By the end of this month, two pharmaceutical firms are set to receive a decision on their drug approval applications from the U.S. Food and Drug Administration (FDA), TipRanks\u2019 FDA Calendar<\/a> shows. <\/p>\n

TipRanks Black Friday Sale<\/p>\n

In this article, we highlight the two companies, detailing the drugs in the lineup for a decision, the function of these medications, and how Wall Street is currently rating these stocks. <\/p>\n

Be sure to click on any ticker for in-depth research before making portfolio decisions. The chart below provides insight into how these two companies compare.<\/p>\n

\"\"<\/a><\/p>\n

Ascendis Pharma (ASND)<\/a> \u2013 This is a Danish biopharma company that specializes in developing therapies for cancer and other rare diseases, such as conditions that affect the hormone-producing glands in the body. It is the maker of Skytrofa, a once-weekly injection for children with low growth hormone, and Yorvipath, a drug that helps to restore the body\u2019s calcium balance.<\/p>\n

The FDA is set to decide on TransCon CNP, another once-weekly therapy by Ascendis, designed to promote bone growth in the body.<\/p>\n

Kura Oncology, Inc. (KURA)<\/a> \u2013 Kura is an American biopharma company that develops medications to target genetic drivers of cancer. Its leading product is Komzifti, a pill that helps treat a specific kind of blood cancer called acute myeloid leukemia (AML). <\/p>\n

Kura is awaiting the FDA\u2019s decision on Ziftomenib, a drug designed to treat AML. <\/p>\n

Which Stock Offers the Most Upside?<\/p>\n

Ascendis and Kura\u2019s shares both currently have a Strong Buy consensus rating from analysts. However, in terms of upside potential, Kura\u2019s shares<\/a>\u00a0comfortably lead, offering a massive upside of 136.20% at an average KURA price target<\/a> of $26.88. <\/p>\n

Ascendis\u2019s shares<\/a> with an average ASND price target<\/a> of $260.15 offer about 23.13% upside.<\/p>\n

Check out other companies with upcoming FDA drug application decisions<\/a>.<\/p>\n

Disclaimer & Disclosure<\/a>Report an Issue<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"By the end of this month, two pharmaceutical firms are set to receive a decision on their drug…\n","protected":false},"author":2,"featured_media":305076,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[97,243],"class_list":{"0":"post-305075","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/305075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=305075"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/305075\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/305076"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=305075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=305075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=305075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}